<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03091972</url>
  </required_header>
  <id_info>
    <org_study_id>LIBCAAF study</org_study_id>
    <nct_id>NCT03091972</nct_id>
  </id_info>
  <brief_title>Liner Ablation Using Contact-force in Atrial Fibrillation</brief_title>
  <acronym>LIBCAAF</acronym>
  <official_title>Left Atrial Liner Block Using Contact-force Catheter in Ablation for Atrial Fibrillation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Korea University Anam Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Biosense Webster, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Korea University Anam Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Linear ablation is frequently used in the procedure for persistent atrial fibrillation.
      However, it has a limitation because of technical difficulty. Incomplete block is common and
      an important cause of atrial tachycardia.

      The association between contact force values and successful linear block has not been
      revealed yet. We aim to the effectiveness and safety of linear ablation by using CF sensing
      catheter.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Catheter ablation is currently accepted as a treatment option for symptomatic atrial
      fibrillation. Linear ablation is frequently used in the procedure for persistent atrial
      fibrillation. Multiple studies have shown benefit of linear ablation. However, it has a
      limitation because of technical difficulty. Incomplete block is common and an important cause
      of atrial tachycardia.

      Contact-force (CF) monitoring during procedure has recently been available. This technology
      appears to significantly decrease procedure time and short term reconnection incidence in
      pulmonary vein (PV) isolation. It also helped to resolve the cause of PV reconnection. Some
      reports demonstrated that the association between reconnection and lower CF value.

      Linear ablation has more variation to interrupt block and reconnection was more often than PV
      isolation. The association between CF values and successful linear block has not been
      revealed yet. In addition, the investigators aim to the effectiveness and safety of linear
      ablation by using CF sensing catheter.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2016</start_date>
  <completion_date type="Anticipated">December 31, 2018</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Freedom from atrial fibrillation/atrial tachycardia</measure>
    <time_frame>12 months</time_frame>
    <description>Freedom from any documented episode of atrial fibrillation/atrial tachycardia occurring after a single ablation procedure and lasting longer than 30 seconds with/without antiarrhythmic medication</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total radiofrequency energy</measure>
    <time_frame>12 months</time_frame>
    <description>Total radiofrequency energy to achieve bidirectional block of linear lesion in left atrium</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total force value</measure>
    <time_frame>12 months</time_frame>
    <description>Total force value for complete block of linear lesion</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Persistent Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>Contact force assisted linear ablation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Left atrial linear ablation performed using the contact force sensing catheter after pulmonary vein isolation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Left atrial linear ablation performed using the catheter without contact force sensing after pulmonary vein isolation</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Pulmonary vein isolation</intervention_name>
    <description>A pulmonary vein isolation procedure will be performed using radiofrequency ablation with contact force monitoring.</description>
    <arm_group_label>Contact force assisted linear ablation</arm_group_label>
    <arm_group_label>control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Contact force assisted left atrial linear ablation</intervention_name>
    <description>Left atrial linear ablation (Roof line and Anterior line) after pulmonary vein isolation during catheter ablation for persistent atrial fibrillation monitoring contact force.</description>
    <arm_group_label>Contact force assisted linear ablation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>left atrial linear ablation without contact force monitoring</intervention_name>
    <description>Left atrial linear ablation (Roof line and Anterior line) after pulmonary vein isolation during catheter ablation for persistent atrial fibrillation without monitoring contact force.</description>
    <arm_group_label>control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients age is18 years or greater

          -  Patients with persistent AF (AF episode lasting &gt; 7 days)

          -  Patients with symptomatic AF that is refractory to at least one antiarrhythmic
             medication

          -  Patients with recurrent or sustained arrhythmia after pulmonary vein isolation

          -  Patients undergoing a first-time ablation procedure for AF

          -  At least one episode of AF must have been documented by ECG, Holter, loop recorder,
             telemetry, trans telephonic monitoring (TTM), or implantable device within last 2
             years of enrollment in this investigation

          -  Patients must be able and willing to provide written informed consent to participate
             in this investigation

        Exclusion Criteria:

          -  Patients with long-standing persistent AF;

          -  Long-standing persistent AF will be defined as a sustained episode lasting more than 3
             years.

          -  Patients for whom cardioversion or sinus rhythm will never be attempted/pursued;

          -  Patients with AF felt to be secondary to an obvious reversible cause

          -  Patients with contraindications to systemic anticoagulation with heparin or warfarin
             or a direct thrombin inhibitor;

          -  Patients with left atrial size ≥ 60 mm (2D echocardiography, parasternal long axis
             view)

          -  Moderate to severe valvular disease

          -  Reduced left ventricular function (ejection fraction &lt;40%)

          -  Patients who are pregnant. Pregnancy will be assessed by patients informing the
             physicians.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Seung-Young Roh, MD</last_name>
    <phone>+82-10-3612-6876</phone>
    <email>rsy008@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kwang No Lee, MD</last_name>
    <phone>+82-10-9286-1123</phone>
    <email>knlee81@naver.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Korea University Medical Center Anam hospital</name>
      <address>
        <city>Seoul</city>
        <zip>02841</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Young-Hoon Kim, President</last_name>
      <phone>+82-2-920-5445</phone>
      <email>yhkmd@unitel.co.kr</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <results_reference>
    <citation>Fassini G, Riva S, Chiodelli R, Trevisi N, Berti M, Carbucicchio C, Maccabelli G, Giraldi F, Bella PD. Left mitral isthmus ablation associated with PV Isolation: long-term results of a prospective randomized study. J Cardiovasc Electrophysiol. 2005 Nov;16(11):1150-6.</citation>
    <PMID>16302895</PMID>
  </results_reference>
  <results_reference>
    <citation>Hocini M, Jaïs P, Sanders P, Takahashi Y, Rotter M, Rostock T, Hsu LF, Sacher F, Reuter S, Clémenty J, Haïssaguerre M. Techniques, evaluation, and consequences of linear block at the left atrial roof in paroxysmal atrial fibrillation: a prospective randomized study. Circulation. 2005 Dec 13;112(24):3688-96.</citation>
    <PMID>16344401</PMID>
  </results_reference>
  <results_reference>
    <citation>Willems S, Klemm H, Rostock T, Brandstrup B, Ventura R, Steven D, Risius T, Lutomsky B, Meinertz T. Substrate modification combined with pulmonary vein isolation improves outcome of catheter ablation in patients with persistent atrial fibrillation: a prospective randomized comparison. Eur Heart J. 2006 Dec;27(23):2871-8. Epub 2006 Jun 16.</citation>
    <PMID>16782716</PMID>
  </results_reference>
  <results_reference>
    <citation>Gaita F, Caponi D, Scaglione M, Montefusco A, Corleto A, Di Monte F, Coin D, Di Donna P, Giustetto C. Long-term clinical results of 2 different ablation strategies in patients with paroxysmal and persistent atrial fibrillation. Circ Arrhythm Electrophysiol. 2008 Oct;1(4):269-75. doi: 10.1161/CIRCEP.108.774885.</citation>
    <PMID>19808418</PMID>
  </results_reference>
  <results_reference>
    <citation>Santucci PA. Linear ablation of atrial fibrillation: what does it do? Heart Rhythm. 2010 Dec;7(12):1738-9. doi: 10.1016/j.hrthm.2010.09.001. Epub 2010 Sep 28.</citation>
    <PMID>20817018</PMID>
  </results_reference>
  <results_reference>
    <citation>Kautzner J, Neuzil P, Lambert H, Peichl P, Petru J, Cihak R, Skoda J, Wichterle D, Wissner E, Yulzari A, Kuck KH. EFFICAS II: optimization of catheter contact force improves outcome of pulmonary vein isolation for paroxysmal atrial fibrillation. Europace. 2015 Aug;17(8):1229-35. doi: 10.1093/europace/euv057. Epub 2015 Jun 3.</citation>
    <PMID>26041872</PMID>
  </results_reference>
  <results_reference>
    <citation>Reddy VY, Dukkipati SR, Neuzil P, Natale A, Albenque JP, Kautzner J, Shah D, Michaud G, Wharton M, Harari D, Mahapatra S, Lambert H, Mansour M. Randomized, Controlled Trial of the Safety and Effectiveness of a Contact Force-Sensing Irrigated Catheter for Ablation of Paroxysmal Atrial Fibrillation: Results of the TactiCath Contact Force Ablation Catheter Study for Atrial Fibrillation (TOCCASTAR) Study. Circulation. 2015 Sep 8;132(10):907-15. doi: 10.1161/CIRCULATIONAHA.114.014092. Epub 2015 Aug 10.</citation>
    <PMID>26260733</PMID>
  </results_reference>
  <results_reference>
    <citation>Andreu D, Gomez-Pulido F, Calvo M, Carlosena-Remírez A, Bisbal F, Borràs R, Benito E, Guasch E, Prat-Gonzalez S, Perea RJ, Brugada J, Berruezo A, Mont L. Contact force threshold for permanent lesion formation in atrial fibrillation ablation: A cardiac magnetic resonance-based study to detect ablation gaps. Heart Rhythm. 2016 Jan;13(1):37-45. doi: 10.1016/j.hrthm.2015.08.010. Epub 2015 Aug 10.</citation>
    <PMID>26272524</PMID>
  </results_reference>
  <results_reference>
    <citation>le Polain de Waroux JB, Weerasooriya R, Anvardeen K, Barbraud C, Marchandise S, De Meester C, Goesaert C, Reis I, Scavee C. Low contact force and force-time integral predict early recovery and dormant conduction revealed by adenosine after pulmonary vein isolation. Europace. 2015 Jun;17(6):877-83. doi: 10.1093/europace/euu329. Epub 2015 Jan 24.</citation>
    <PMID>25618742</PMID>
  </results_reference>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 31, 2017</study_first_submitted>
  <study_first_submitted_qc>March 21, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 27, 2017</study_first_posted>
  <last_update_submitted>March 21, 2017</last_update_submitted>
  <last_update_submitted_qc>March 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Korea University Anam Hospital</investigator_affiliation>
    <investigator_full_name>Young-Hoon Kim</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Persistent Atrial Fibrillation</keyword>
  <keyword>Linear ablation</keyword>
  <keyword>Catheter ablation</keyword>
  <keyword>Contact force</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

